• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Claritev Appoints Jason Kap to its Board of Directors

    5/1/25 8:00:00 AM ET
    $CTEV
    Business Services
    Consumer Discretionary
    Get the next $CTEV alert in real time by email

    Board gains deep technology and innovation expertise to support Claritev's tech-driven growth strategy

    Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, yesterday announced the appointment of Jason Kap to its Board of Directors, effective immediately following his election at the Company's Annual Meeting of Shareholders on April 30, 2025. Kap brings more than two decades of leadership experience driving technology, pricing and product transformation strategies across the software and services industries, strengthening Claritev's focus on building a next-generation, tech-centric platform.

    Kap currently serves as the founder and Chief Executive Officer of Blue Rocket Incorporated, a pricing and product transformation company. Previously, he was the Chief Executive Officer of Zipwire, Inc., and spent over 16 years at Microsoft Corporation in a series of leadership roles, culminating as General Manager and Senior Director of Worldwide Licensing and Pricing. Kap also served as a visiting scholar at the Massachusetts Institute of Technology (MIT) from 2013 to 2020 and currently serves on the board of directors of HitchPin, Inc. He previously served on the board for several other private companies, including Tarian Technology Corp.

    "Jason's extensive background in technology, pricing and innovation strategy makes him an ideal addition to our Board as we advance our technology-driven transformation," said Travis Dalton, Chairman, CEO and President of Claritev. "His expertise in leading product innovation and business transformation at some of the world's most respected organizations will be a tremendous asset as we continue to deliver solutions that drive greater value for our customers and the healthcare system."

    Kap's appointment comes as Claritev accelerates its focus on using technology, data and insights to make healthcare more affordable, transparent and fair for all. Building on its leadership in healthcare cost optimization and revenue integrity solutions, Claritev is expanding its capabilities through strategic investments, platform enhancements and partnerships to help deliver greater value for employers, payers and patients across the healthcare ecosystem.

    "Claritev's vision to drive affordability, transparency and quality through technology and innovation is both exciting and essential to the future of healthcare," said Kap. "I look forward to working with the Board and management team to help Claritev accelerate its growth and deliver even greater impact for its customers and the broader healthcare ecosystem."

    About Claritev

    Claritev, formerly known as MultiPlan, is a healthcare technology, data and insights company focused on delivering affordability, transparency and quality to the U.S. healthcare system. Led by a team of deeply experienced associates, data scientists and innovators, Claritev provides cutting-edge solutions and services fueled by over 40 years of claims processing data. Claritev leverages world-class technology and AI to power a robust enterprise platform that delivers meaningful insights to drive affordability and price transparency and optimizes networks and benefits design in healthcare. By developing purpose-built solutions that support all key stakeholders — including payors, employers, patients, providers and third parties — Claritev is dedicated to making healthcare more accessible and affordable for all.

    Claritev serves more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit claritev.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250429862058/en/

    Media Relations

    Pamela Walker

    VP, Corporate Marketing

    Claritev

    781-895-3118

    [email protected]

    Investor Relations

    Jason Wong

    SVP, Treasury & Investor Relations

    Claritev

    866-909-7427

    [email protected]

    Shawna Gasik

    AVP, Investor Relations

    Claritev

    866-909-7427

    [email protected]

    Get the next $CTEV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CTEV

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CTEV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP, Chief Operating Officer Hogge Jerome bought $349,250 worth of shares (12,500 units at $27.94), increasing direct ownership by 17% to 84,402 units (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      5/20/25 4:24:37 PM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • EVP&CFO Garis Douglas Michael bought $99,828 worth of shares (3,600 units at $27.73), increasing direct ownership by 3% to 143,861 units (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      5/20/25 4:23:54 PM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Pres., CEO & Executive Chair Dalton Travis bought $99,984 worth of shares (3,773 units at $26.50), increasing direct ownership by 2% to 243,058 units (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      5/16/25 4:23:45 PM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    Financials

    Live finance-specific insights

    See more
    • Claritev Corporation Reports First Quarter 2025 Results

      – Q1 2025 Revenues of $231.3 million, Net Loss of $71.3 million, and Adjusted EBITDA of $142.1 million (Adjusted EBITDA Margin of 61.4%) – Reaffirms full-year guidance Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the first quarter ended March 31, 2025. "There is tremendous excitement at Claritev as we kick off 2025 - our ‘Year of The Turn.' We've already announced major milestones, and our teams are amplifying this positive momentum as we continue on our planned course for the year," said Travis Dalton, Chairman, CEO a

      5/8/25 6:00:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev Corporation Announces First Quarter 2025 Earnings Conference Call

      Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its first quarter 2025 financial results on Thursday, May 8, 2025, and hold its conference call that morning at 8:00 am Eastern Time. To join the conference call, please pre-register using the link below. Participants who pre-register will receive a calendar invitation with call access details including a unique PIN. Pre-registration may be completed at any time up to and following the call start time. To pre-register, go to: https://www.netroadshow.com/events/login?show=fda0

      4/10/25 8:30:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP, Chief Operating Officer Hogge Jerome bought $349,250 worth of shares (12,500 units at $27.94), increasing direct ownership by 17% to 84,402 units (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      5/20/25 4:24:37 PM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • EVP&CFO Garis Douglas Michael bought $99,828 worth of shares (3,600 units at $27.73), increasing direct ownership by 3% to 143,861 units (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      5/20/25 4:23:54 PM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Pres., CEO & Executive Chair Dalton Travis bought $99,984 worth of shares (3,773 units at $26.50), increasing direct ownership by 2% to 243,058 units (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      5/16/25 4:23:45 PM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    Leadership Updates

    Live Leadership Updates

    See more
    • Great Speech's Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev's National PPO Networks

      HOLLYWOOD, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Great Speech, a national leader in virtual speech therapy, is proud to announce a new agreement with Claritev, formerly known as MultiPlan (NYSE:CTEV), a technology and data insights company focused on making healthcare more affordable, transparent and fair for all. This network participation agreement marks a major step forward in expanding access to high-quality, convenient, and personalized speech therapy services for individuals and families nationwide. Great Speech's innovative teletherapy services will now be available to health plan members accessing Claritev's MultiPlan and PHCS Networks. The initiative aims to eliminate traditio

      5/6/25 10:02:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev Appoints Jason Kap to its Board of Directors

      Board gains deep technology and innovation expertise to support Claritev's tech-driven growth strategy Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, yesterday announced the appointment of Jason Kap to its Board of Directors, effective immediately following his election at the Company's Annual Meeting of Shareholders on April 30, 2025. Kap brings more than two decades of leadership experience driving technology, pricing and product transformation strategies across the software and services industries, strengthening Claritev's focus on building a next-generati

      5/1/25 8:00:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Claritev and Burjeel Holdings Finalize Strategic Collaboration, Marks Claritev's Expansion into the Middle East

      This agreement follows the previous announcement of a memorandum of understanding signed last month. Claritev Corporation ("Claritev") (NYSE:CTEV) and Claims Care Revenue Cycle Management LLC ("Claims Care" or "CCRCM"), a division of Burjeel Holdings (ADX: BURJEEL), are pleased to announce the formalization of their strategic relationship, following the signing of a memorandum of understanding ("MoU") announced last month. This collaboration aims to revolutionize revenue cycle management ("RCM") in the Middle East and North Africa ("MENA") region by bringing the power of Claritev's advanced claims analytics and AI-driven solutions together with Claims Care's extensive regional expertise.

      5/22/25 10:45:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev Corporation Reports First Quarter 2025 Results

      – Q1 2025 Revenues of $231.3 million, Net Loss of $71.3 million, and Adjusted EBITDA of $142.1 million (Adjusted EBITDA Margin of 61.4%) – Reaffirms full-year guidance Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the first quarter ended March 31, 2025. "There is tremendous excitement at Claritev as we kick off 2025 - our ‘Year of The Turn.' We've already announced major milestones, and our teams are amplifying this positive momentum as we continue on our planned course for the year," said Travis Dalton, Chairman, CEO a

      5/8/25 6:00:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev and Lantern Form Strategic Partnership to Enhance Surgical Cost Transparency and Positively Impact Care Quality and Cost Savings

      The partnership integrates Claritev's innovative solutions with Lantern's Specialty Care Platform to optimize healthcare costs for Lantern's footprint. Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced an agreement with Lantern, a Specialty Care Platform that helps employers reduce costs and improve health outcomes for surgery, cancer and infusions care. This strategic partnership brings together Claritev's award-winning BenInsights® and HST Connect® solutions with Lantern's Network of Excellence and TrueRateTM savings methodology to create a pow

      5/7/25 8:00:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    SEC Filings

    See more
    • SEC Form S-8 filed by Claritev Corporation

      S-8 - Claritev Corp (0001793229) (Filer)

      5/9/25 8:05:24 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • SEC Form 10-Q filed by Claritev Corporation

      10-Q - Claritev Corp (0001793229) (Filer)

      5/9/25 7:40:59 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Claritev Corp (0001793229) (Filer)

      5/8/25 6:04:59 AM ET
      $CTEV
      Business Services
      Consumer Discretionary